A Missouri bill which would require products containing mRNA drugs to be labeled was voted down last week in committee.

HB1169 proposes that any product containing a “gene therapy” such as an mRNA vaccine and is exposed to the human body displays the words “Potential Gene Therapy Product” on the label. The legislation also would require companies who make products that act as medical interventions, vaccines, drugs, or genetic modifications to first obtain fully informed consent from any individual using the product. This would include making the individual aware of all benefits and risks, including side effects.

“We label everything around the world. We label non-GMO. We label GMO. We label grass-fed. We label no antibiotics used. We label manufactured in a plant that has nuts,” Rep. Holly Jones, the Republican who sponsored the bill, said.

“We should label anything that has not been proven safe and effective. As we’ve seen with the COVID vaccines, they’re neither safe nor effective. Even the CDC has come out with that.”

Jones’ bill follows proposed legislation in several other states which seek to ban mRNA products from being given to livestock, or at least require full disclosure when they are.

Tennessee House Bill 0099, for example, seeks to outlaw the sale of any meat product injected with a vaccine unless the product conspicuously discloses that fact. The bill specifically mentions mRNA by name.

Arizona House Bill 2762, currently in committee, would require all seafood, poultry and meat products which contain mRNA vaccine material to disclose that on the label. It would also prohibit those products from being labeled “organic”.

Idaho House Bill 154 would make administering an mRNA shot a misdemeanor.

The chief concern driving such legislation is that the mRNA gene therapy may transfer to humans who consume the products.

This concern is well-founded. A study published in December from Chinese firm Tingo Exosomes Technology Co. found that when an mRNA COVID-19 vaccine using milk-derived exosomes was administered orally to mice, the rodents absorbed the mRNA into their bloodstream and produced the antibodies.

“This is a new, dark phase of messenger RNA exposure to human beings,” said world-renowned cardiologist Dr. Peter McCullough.

“We should be very concerned about messenger RNA in the food supply. We use genetically modified organisms in food to grow big apples and big strawberries. The genetic use of technology to improve various forms of food, to make them grow more readily—I think that’s well understood.

“But the idea of using food as a delivery mechanism to humans and change something within the human body, that’s a new aspiration. We’re seeing it from the Chinese.”

The Missouri Cattlemen’s Association’s Mike Deering reacted to HB1169, saying no mRNA vaccines are used in the beef industry and that any vaccines that are administered to livestock are completely absorbed by the animals.

“So, there is absolutely no component, no residue, of that vaccine left in the meat whatsoever,” said Deering.

But while the US beef industry is not currently using mRNA vaccines, it doesn’t mean it won’t.

Iowa State University’s Veterinary Microbiology and Preventive Medicine Department is developing an mRNA vaccine for the bovine respiratory syncytial virus (RSV), which can lead to pneumonia in cattle if untreated, reports The Epoch Times.

The government of Queensland, Australia has so far invested $1.5 million in developing an mRNA vaccine for bovine Lumpy Skin Disease (LSD).

Genvax Technologies, an mRNA vaccine research startup, has already received $6.5 million in private funding and is eager to develop vaccines for animals.

“The threat posed to producers and consumers by foreign animal diseases like African swine fever (ASF) and constantly mutating variants of swine influenza is extraordinary,” Genvax Technologies CEO and co-founder Joel Harris said.

“The goal is to develop a vaccine that matches 100 percent to the specific strain when a disease outbreak occurs.”